ENvue Medical (FEED) Cash from Financing Activities (2014 - 2026)
ENvue Medical (FEED) posted quarterly Cash from Financing Activities of $2.3 million for Q1 2026, up 122.86% year-over-year from $1.0 million in Q1 2025, and up 6982.35% quarter-over-quarter from -$34000.0 in Q4 2025.
ENvue Medical (FEED) Cash from Financing Activities (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Cash from Financing Activities for 12 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 122.86% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $14.1 million (up 1275.95% YoY), while the FY2025 annual figure was $12.8 million, up 1278500.0% from the prior year.
- Cash from Financing Activities advanced to $2.3 million in Q1 2026 per FEED's latest filing, from -$34000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $6.8 million in Q2 2025 and bottomed at -$34000.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged $2.4 million across 4 years, with a median of $1.7 million in 2025.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities sank 100.64% — and 2025, when it surged 18322.22%.
- ENvue Medical's Cash from Financing Activities stood at $4.2 million in 2023, then plunged by 100.64% to -$27000.0 in 2024, then declined by 25.93% to -$34000.0 in 2025, then soared by 6982.35% to $2.3 million in 2026.
- Business Quant data shows FEED's Cash from Financing Activities at $2.3 million in Q1 2026, -$34000.0 in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | -213.50 Mn |
| 10 | ENvue Medical | 2.50 Mn | 1.36 Mn | -266,000.00 | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | -34,000.00 |
| Dec 31, 2025 | -34,000.00 |
| Sep 30, 2025 | 4.92 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Sep 30, 2024 | -27,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Sep 30, 2023 | 4.22 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Sep 30, 2021 | 3.56 Mn |
| Sep 30, 2021 | 3.56 Mn |